JP2024528935A5 - - Google Patents
Info
- Publication number
- JP2024528935A5 JP2024528935A5 JP2024506163A JP2024506163A JP2024528935A5 JP 2024528935 A5 JP2024528935 A5 JP 2024528935A5 JP 2024506163 A JP2024506163 A JP 2024506163A JP 2024506163 A JP2024506163 A JP 2024506163A JP 2024528935 A5 JP2024528935 A5 JP 2024528935A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163228195P | 2021-08-02 | 2021-08-02 | |
| US63/228,195 | 2021-08-02 | ||
| PCT/US2022/074409 WO2023015170A2 (en) | 2021-08-02 | 2022-08-02 | Anti-cd38 antibodies, anti-cd3 antibodies, and bispecific antibodies, and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024528935A JP2024528935A (ja) | 2024-08-01 |
| JPWO2023015170A5 JPWO2023015170A5 (https=) | 2025-09-11 |
| JP2024528935A5 true JP2024528935A5 (https=) | 2025-09-11 |
Family
ID=83049800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506163A Withdrawn JP2024528935A (ja) | 2021-08-02 | 2022-08-02 | 抗ｃｄ３８抗体、抗ｃｄ３抗体、及び二重特異性抗体、並びにその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250277051A1 (https=) |
| EP (1) | EP4380977A2 (https=) |
| JP (1) | JP2024528935A (https=) |
| KR (1) | KR20240042009A (https=) |
| CN (1) | CN117751144A (https=) |
| AU (1) | AU2022323166A1 (https=) |
| CA (1) | CA3226428A1 (https=) |
| IL (1) | IL310024A (https=) |
| WO (1) | WO2023015170A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117327186B (zh) * | 2023-07-12 | 2024-03-12 | 北京达成生物科技有限公司 | 结合mmp3蛋白的双特异性抗体及其用途 |
| WO2025162453A1 (zh) * | 2024-02-02 | 2025-08-07 | 北京昌平实验室 | 双特异性抗体前药及其应用 |
| WO2025201240A1 (en) * | 2024-03-25 | 2025-10-02 | Tavotek Biotherapeutics (Hong Kong) Limited | Antibodies targeting cd3, cd28, and pd-l1 and uses thereof |
| WO2025201242A1 (en) * | 2024-03-25 | 2025-10-02 | Tavotek Biotherapeutics (Hong Kong) Limited | Antibodies targeting fap and lrrc15 and fusion proteins targeting hyaluronan and uses thereof |
| CN119236080A (zh) * | 2024-09-29 | 2025-01-03 | 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） | 一种医药组合物在制备用于治疗多发性硬化药物中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| ATE87659T1 (de) | 1986-09-02 | 1993-04-15 | Enzon Lab Inc | Bindungsmolekuele mit einzelpolypeptidkette. |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE199392T1 (de) | 1992-12-04 | 2001-03-15 | Medical Res Council | Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| EP1789446A2 (en) | 2004-09-02 | 2007-05-30 | Genentech, Inc. | Heteromultimeric molecules |
| EP3050963B1 (en) | 2005-03-31 | 2019-09-18 | Chugai Seiyaku Kabushiki Kaisha | Process for production of polypeptide by regulation of assembly |
| DE102005028778A1 (de) | 2005-06-22 | 2006-12-28 | SUNJÜT Deutschland GmbH | Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage |
| WO2007147901A1 (en) | 2006-06-22 | 2007-12-27 | Novo Nordisk A/S | Production of bispecific antibodies |
| JP2012525149A (ja) | 2009-04-27 | 2012-10-22 | オンコメッド ファーマシューティカルズ インコーポレイテッド | ヘテロ多量体分子を作製するための方法 |
| UA118255C2 (uk) * | 2012-12-07 | 2018-12-26 | Санофі | Композиція, яка містить антитіло до cd38 і леналідомід |
| JP6775422B2 (ja) * | 2014-03-28 | 2020-10-28 | ゼンコー・インコーポレイテッドＸｅｎｃｏｒ、 Ｉｎｃ． | Ｃｄ３８及びｃｄ３に結合する二重特異性抗体 |
| US11773166B2 (en) * | 2014-11-04 | 2023-10-03 | Ichnos Sciences SA | CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production |
| MA43219A (fr) * | 2015-11-10 | 2018-09-19 | Univ Medical Center Hamburg Eppendorf | Polypeptides de liaison d'antigène dirigés contre cd38 |
| CA3078800A1 (en) * | 2017-10-10 | 2019-04-18 | Sanofi | Anti-cd38 antibodies and methods of use |
| BR112021000173A2 (pt) * | 2018-10-26 | 2021-05-04 | Teneobio, Inc. | anticorpos de cadeia pesada com ligação a cd38 |
| CA3144961A1 (en) * | 2019-07-01 | 2021-01-07 | Sorrento Therapeutics, Inc. | Heterodimeric antibodies that bind to cd38 and cd3 |
-
2022
- 2022-08-01 US US18/294,406 patent/US20250277051A1/en active Pending
- 2022-08-02 CA CA3226428A patent/CA3226428A1/en active Pending
- 2022-08-02 KR KR1020247007197A patent/KR20240042009A/ko active Pending
- 2022-08-02 JP JP2024506163A patent/JP2024528935A/ja not_active Withdrawn
- 2022-08-02 EP EP22758399.4A patent/EP4380977A2/en active Pending
- 2022-08-02 AU AU2022323166A patent/AU2022323166A1/en active Pending
- 2022-08-02 WO PCT/US2022/074409 patent/WO2023015170A2/en not_active Ceased
- 2022-08-02 CN CN202280053639.9A patent/CN117751144A/zh active Pending
- 2022-08-02 IL IL310024A patent/IL310024A/en unknown